Find a company
Search the SBRI Healthcare and NHS Cancer Programme Innovation Open call portfolio.
If you would like further information on any of the companies listed in the Directory please contact the SBRI Healthcare PMO by email sbri@lgcgroup.com or tel: +44 20 8843 8125.
We would be happy to make introductions to the companies or provide any further feedback you require.
At a glance
Directory search results
Upfront Diagnostics (formerly Pockit diagnostics Ltd)
Project | A point-of-care blood test for the pre-hospital identification of stroke patients suitable for emergency thrombectomy treatment |
---|---|
Description |
Stroke due to large vessel occlusion (LVO) contributes very significantly towards global adult disability and care costs. This burden is reduced when a specialist surgical treatment (thrombectomy) is performed rapidly within the first 6 hours. However most patients are first admitted to a local hospital, which cannot provide treatment. Suitable patients must be transferred onto the nearest thrombectomy centre, delaying treatment by ~2 hours, with corresponding poorer outcomes. Our technology could allow LVO detection in ambulances, enabling direct admission of selected patients to thrombectomy centres. Having previously demonstrated 95% accuracy for LVO detection using laboratory assays, we are developing a portable blood test. We will validate the test on biobank of samples and collect feedback from end-users and stroke survivors. |
Funding | £ 881,931 |
Competition | Competition 18 - Stroke and Technology |
Competition Date | June 2021 |
Categories | Stroke , Blood |
Website | http://www.upfrontdiagnostics.com/ |
Upfront Diagnostics (formerly Pockit diagnostics Ltd)
Project | Real-world evidence for NHS adoption of a point-of-care blood-test for pre-hospital identification of stroke patients suitable for thrombectomy treatment (LVOne-Pathway) |
---|---|
Description |
LVOne is a novel rapid blood test for diagnosing severe stroke patients who need rapid treatment with mechanical thrombectomy. By using only a small fingerstick sample of blood, the test measures 2 protein biomarkers that the company has discovered, validated, and patented. LVOne is designed to be used in ambulance, so that patients can be identified early and fast-tracked to treatment. This project will investigate: 1) barriers/facilitators of LVOne's implementation in the real-world, 2) Accuracy for identification of treatment eligibility and not just clinical condition, 3) Health economics. |
Funding | £ 500,000 |
Competition | Competition 26 - Stroke |
Competition Date | July 2024 |
Categories | Stroke |
Website | http://www.upfrontdiagnostics.com/ |
Cognitant Group Ltd
Project | Providing a coordinated, connected world for stroke survivors and their families through a personalised, digital support package: the ‘My Stroke Companion’ hub. |
---|---|
Description |
There are 1.3 million stroke survivors in the UK living with potentially life-changing consequences.
1 in 4 stroke survivors do not understand their diagnosis. Better patient understanding of their condition has the potential to reduce the likelihood of having a second stroke, improve quality of life, save lives and yield significant savings. The ‘My Stroke Companion’ hub will:
It will be disseminated to patients by healthcare professionals upon hospital discharge, enabling patients to view content on smartphones, tablets, computers and in print. |
Funding | £ 500,755 |
Competition | Competition 18 - Stroke and Technology |
Competition Date | June 2021 |
Categories | Stroke |
Health Innovation Network Partner | Health Innovation Oxford & Thames Valley |
Website | https://www.cognitant.com |